ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P TSX Capped Composite...
32.30
(
0.65%
)
US Tech 100
15,532.00
(
-0.39%
)
S&P 500
4,567.80
(
0.38%
)
US Dollar vs CAD
1.35595
(
-0.23%
)
Bitcoin
37,716.53
(
-0.40%
)
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Quince Therapeutics Inc (QNCX)

  7. Quince Therapeutics Inc (QNCX) News

QNCX Quince Therapeutics Inc

0.8893
-0.0508 (-5.4%)
After Hours
Last Updated: 16:01:21
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Quince Therapeutics Inc QNCX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.0508 -5.4% 0.8893 16:01:21
Open Price Low Price High Price Close Price Previous Close
0.966 0.852901 0.9684 0.89 0.9401
more quote information »

Recent News

Date Time Source Heading
10/26/202316:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/24/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/24/202318:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/23/202315:05EDGAR2Form 8-K - Current report
10/23/202306:00BWQuince Therapeutics Completes Acquisition of EryDel S.p.A.
9/28/202315:53DJNQuince Therapeutics to Advance Study of EryDex as FDA Lifts..
9/28/202315:05BWU.S. FDA Partial Clinical Hold Lifted on IND for EryDel’s..
9/06/202306:18EDGAR2Form 8-K - Current report
9/06/202306:00BWQuince Therapeutics Appoints Dr. Charles S. Ryan as..
8/31/202317:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/17/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:05EDGAR2Form 8-K - Current report
8/10/202315:05BWQuince Therapeutics to Present at Sidoti Virtual Investor..
8/09/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/09/202317:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/03/202315:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/24/202316:56BWQuince Therapeutics rileva EryDel SpA e il suo asset di fase..
7/24/202306:16EDGAR2Form 8-K - Current report
7/24/202306:00BWQuince Therapeutics to Acquire EryDel SpA and its Phase 3..
4/11/202306:00BWQuince Therapeutics Board of Directors Unanimously Rejects..
4/06/202315:05BWQuince Therapeutics Engages MTS Health Partners as..
4/05/202315:05BWQuince Therapeutics Adopts Limited Duration Stockholders..
3/22/202304:00BWQuince Therapeutics Confirms Receipt of Unsolicited..
3/21/202316:10APSAnother Biotech Massively Outperforms Broader Equities
1/30/202315:05BWQuince Therapeutics Provides Pipeline Update and Business..
1/27/202307:00BWQuince Therapeutics Completes the Sale of Legacy Protease..

Your Recent History

NASDAQ
QNCX
Quince Therapeutics
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com